Lonza · 6 hours ago
QC Analyst II, Micro
Lonza is a global leader in life sciences manufacturing, and they are seeking a QC Analyst II in Micro to execute microbiological tests and maintain laboratory operations. The role involves performing assays, coordinating microbial isolations, and ensuring compliance with guidelines and protocols.
BiotechnologyLife SciencePharmaceutical
Responsibilities
Performance and sample tracking of bioburden assays
Performance of microbiological assays for media, raw material, and product release
Coordination and performance of microbial isolations and identifications
Assistance with maintenance of the laboratories, supplies, and equipment
Completes documentation in accordance with GDP
Supports the execution of validation protocols
Maintains compliance with all required training
Aseptic manipulation testing qualification is required. There will be events where many hours working within a biosafety cabinet is required, and work hours may vary dependent on the demands of individual manufacture events
Qualification
Required
Associates in Life Science or Chemistry
2+ years' experience in QC/QA in Pharma, Biotech, or Food lab environment
Biosafety Cabinet operation experience
Aseptic techniques
BSL-2 experience
Aseptic manipulation testing qualification is required
Preferred
BA / BS in Microbiology or related field
Benefits
Performance-related bonus.
Medical, dental and vision insurance.
401(k) matching plan.
Life insurance, as well as short-term and long-term disability insurance.
Employee assistance programs.
Paid time off (PTO).
Company
Lonza
Lonza Group supplies products and services to pharmaceutical and agrochemical industries.
H1B Sponsorship
Lonza has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2024 (3)
2022 (1)
2021 (3)
2020 (2)
Funding
Current Stage
Public CompanyTotal Funding
$444.8M2023-11-06Post Ipo Debt· $444.8M
2020-12-07IPO
Recent News
NH Business Review
2026-01-17
Company data provided by crunchbase